- Home
- ABOS vs FINW Comparison
ABOS vs FINW Comparison
Compare ABOS & FINW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ABOS | FINW |
|---|---|---|
| Founded | 1996 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Commercial Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 113.9M | 242.1M |
| IPO Year | 2021 | 2021 |
Fundamental Metrics
Financial Performance| Metric | ABOS | FINW |
|---|---|---|
| Price | $2.10 | $18.05 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 3 |
| Target Price | $7.67 | ★ $21.67 |
| AVG Volume (30 Days) | ★ 151.0K | 14.5K |
| Earning Date | 11-12-2025 | 01-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.05 |
| Revenue | N/A | ★ $80,198,000.00 |
| Revenue This Year | N/A | $72.14 |
| Revenue Next Year | N/A | $47.30 |
| P/E Ratio | ★ N/A | $16.92 |
| Revenue Growth | N/A | ★ 14.76 |
| 52 Week Low | $0.86 | $13.49 |
| 52 Week High | $2.46 | $22.49 |
Technical Indicators
Market Signals| Indicator | ABOS | FINW |
|---|---|---|
| Relative Strength Index (RSI) | 58.21 | 49.57 |
| Support Level | $1.97 | $17.47 |
| Resistance Level | $2.19 | $18.14 |
| Average True Range (ATR) | 0.13 | 0.43 |
| MACD | 0.03 | 0.01 |
| Stochastic Oscillator | 79.55 | 61.98 |
Price Performance
Historical ComparisonAbout ABOS Acumen Pharmaceuticals Inc.
Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what it believes to be a key underlying cause of Alzheimer's disease. The company's drug candidate, ACU193, is a subclass monoclonal antibody that selectively targets amyloid-beta oligomers.
About FINW FinWise Bancorp
FinWise Bancorp is an independent bank that provides a full range of banking services to individual and corporate customers. The bank's primary source of revenue is from loans, including Small Business Administration, commercial, commercial real estate, residential real estate, and consumer. The Bank has also established Strategic Programs with various third-party loan origination platforms that use technology to streamline the origination of unsecured consumer and secured or unsecured business loans to borrowers within certain approved credit profiles.